Aptamer Innovations (AI) is a bio-tech startup focusing on RNA Therapeutic tools and Diagnostic technologies. We develop and commercialize rapid and robust RNA imaging and purification technologies for use by the general Biomedical community by leveraging existing patented fluorescent nucleic acid technology.
A collection of state-of-the-art high affinity RNA aptamers that can be used for RNA imaging and purification. This technology consists of a mature technology base and is being actively developed by AI.
The high contrast and fluorophore exchange properties of Mango aptamers enable a broad range of state-of-the-art super-resolution imaging techniques and that are fully compatible with widely used protein-protein technologies.
SFU Faculty of Science Professor Peter Unrau joins Joy Johnson, VP Research and International, SFU, in a discussion about Mango, a state-of-the-art imaging technology that is being used within coronavirus testing kits and the potential uses in detecting other viruses, such as the seasonal flu.
SFU Post-Doctoral Fellow Lena Dolgosheina and Professor Peter Unrau of Molecular Biology and Biochemistry are using their previously developed imaging technology called Mango to help produce cheaper and faster COVID-19 testing kits.
In this first virtual Cafe Scientifique video, Dr. Peter Unrau describes his work in creating Rapid Viral Testing Developments for COVID-19 and other diseases.
A new hope in the battle against coronavirus is on the way from a team of researchers at Canada’s Simon Fraser University.
